Moving more potent and less toxic options to the frontline in the management of advanced lung cancer

The most common primary lung cancers can be divided into small cell lung cancer and non-small cell lung cancer (NSCLC)—the latter compromised predominantly of adenocarcinoma and squamous cell carcinoma histologies